tiprankstipranks
Advertisement
Advertisement

HK:6990 Stock Latest News

Kelun-Biotech’s sac-TMT Wins Priority Review for New Lung Cancer Use in China
Company AnnouncementsKelun-Biotech’s sac-TMT Wins Priority Review for New Lung Cancer Use in China
3d ago
6990
Sichuan Kelun-Biotech Completes H Share Full Circulation Conversion
PremiumCompany Announcements
Sichuan Kelun-Biotech Completes H Share Full Circulation Conversion
24d ago
6990
Kelun-Biotech Commits RMB690 Million to Structured Deposits in Treasury Move
PremiumCompany Announcements
Kelun-Biotech Commits RMB690 Million to Structured Deposits in Treasury Move
26d ago
6990
Kelun-Biotech Drops Biotech Marker After Meeting Main Board Listing Thresholds
PremiumCompany Announcements
Kelun-Biotech Drops Biotech Marker After Meeting Main Board Listing Thresholds
1M ago
6990
Sichuan Kelun-Biotech Wins Approval for Full Circulation of Additional H Shares
PremiumCompany Announcements
Sichuan Kelun-Biotech Wins Approval for Full Circulation of Additional H Shares
1M ago
6990
Kelun-Biotech Wins CSRC Nod for H Share Full Circulation
PremiumCompany AnnouncementsKelun-Biotech Wins CSRC Nod for H Share Full Circulation
2M ago
6990
Kelun-Biotech: Transitioning to Commercial Growth with sac-TMT as a Key Value Driver Supporting a Sustained Buy Rating
Premium
Ratings
Kelun-Biotech: Transitioning to Commercial Growth with sac-TMT as a Key Value Driver Supporting a Sustained Buy Rating
2M ago
Kelun-Biotech Wins NMPA Green Light to Begin Trials of Novel Bispecific ADC SKB103
Premium
Company Announcements
Kelun-Biotech Wins NMPA Green Light to Begin Trials of Novel Bispecific ADC SKB103
2M ago
6990
Kelun-Biotech Widens Losses as It Accelerates ADC Push and Wins New China Approvals
PremiumCompany Announcements
Kelun-Biotech Widens Losses as It Accelerates ADC Push and Wins New China Approvals
2M ago
6990
Kelun-Biotech’s Sacituzumab Tirumotecan Strengthens Lead in EGFR-Mutant Lung Cancer With Final Survival Data
PremiumCompany Announcements
Kelun-Biotech’s Sacituzumab Tirumotecan Strengthens Lead in EGFR-Mutant Lung Cancer With Final Survival Data
2M ago
6990
Kelun-Biotech Sets March 2026 Board Meeting and Webcast for 2025 Results
PremiumCompany Announcements
Kelun-Biotech Sets March 2026 Board Meeting and Webcast for 2025 Results
2M ago
6990
Kelun-Biotech Signs Connected Marketing Deal for Key TROP2 Cancer Drug
PremiumCompany Announcements
Kelun-Biotech Signs Connected Marketing Deal for Key TROP2 Cancer Drug
2M ago
6990
Kelun-Biotech Wins NMPA IND Nod for Long-Acting Atopic Dermatitis Antibody
PremiumCompany AnnouncementsKelun-Biotech Wins NMPA IND Nod for Long-Acting Atopic Dermatitis Antibody
2M ago
6990
Kelun-Biotech Wins Fourth China Indication for Core TROP2 ADC in Advanced Breast Cancer
Premium
Company Announcements
Kelun-Biotech Wins Fourth China Indication for Core TROP2 ADC in Advanced Breast Cancer
3M ago
6990
Kelun-Biotech Details Pricing Controls for 2026 Connected R&D Procurement
Premium
Company Announcements
Kelun-Biotech Details Pricing Controls for 2026 Connected R&D Procurement
4M ago
6990
Kelun-Biotech Signs New Connected R&D Goods Supply Deal With China Resources Kelun
PremiumCompany Announcements
Kelun-Biotech Signs New Connected R&D Goods Supply Deal With China Resources Kelun
4M ago
6990
Sichuan Kelun-Biotech Cancels RMB980 Million Structured Deposit Subscription
PremiumCompany Announcements
Sichuan Kelun-Biotech Cancels RMB980 Million Structured Deposit Subscription
4M ago
6990
Kelun-Biotech Commits RMB1.82 Billion to New Structured Deposits With BOC and BOCOM
PremiumCompany Announcements
Kelun-Biotech Commits RMB1.82 Billion to New Structured Deposits With BOC and BOCOM
4M ago
6990
Kelun-Biotech’s ADC-PD-1 Combo Wins Breakthrough Therapy Status in First-Line Lung Cancer
PremiumCompany Announcements
Kelun-Biotech’s ADC-PD-1 Combo Wins Breakthrough Therapy Status in First-Line Lung Cancer
4M ago
6990
Kelun-Biotech Wins NMPA IND Nod for ITGB6-Targeted ADC SKB105 and Advances Oncology Collaboration With Crescent
PremiumCompany AnnouncementsKelun-Biotech Wins NMPA IND Nod for ITGB6-Targeted ADC SKB105 and Advances Oncology Collaboration With Crescent
4M ago
6990
Kelun-Biotech Renews Connected Distribution Deal With China Resources Kelun to 2028
Premium
Company Announcements
Kelun-Biotech Renews Connected Distribution Deal With China Resources Kelun to 2028
4M ago
6990
Kelun-Biotech Wins Strong Shareholder Backing for 2026 Connected Deals and New Share Incentive Plan
Premium
Company Announcements
Kelun-Biotech Wins Strong Shareholder Backing for 2026 Connected Deals and New Share Incentive Plan
4M ago
6990

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >